← SynDRA
GSK-J1
SynDRA canonical compound SYN0059871 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | KDM6A | KDM6B | TNF |
|---|
| Mechanism of action | histone demethylase inhibitor |
|---|
All known targets
- KDM6B
- KDM6A
- KDM5A
- KDM5B
- KDM5C
- TNF
Mechanisms of action (all sources)
- KDM5A INHIBITOR
- KDM5B INHIBITOR
- KDM5C INHIBITOR
- KDM6A INHIBITOR
- KDM6B INHIBITOR
- histone demethylase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- GSK J1
- 3-{[2-(pyridin-2-yl)-6-(2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl)pyrimidin-4-yl]amino}propanoic acid
- 3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid
- 3-[[2-Pyridin-2-Yl-6-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)pyrimidin-4-Yl]amino]propanoic Acid
- GSKJ1
- MLS006010249
- GTPL7027
- SCHEMBL10157115
- CHEMBL3188597
- BDBM60875
- EX-A571
- AOB3940
- CHEBI:131152
- MolPort-023-278-906
- EX-A1744
- BCP08262
- ZINC95616592
- s7581
- 2442AH
- AKOS024458240
- RefChem:1086195
- MFCD22683851
- GSKJ1; GSK-J1
- GSK-J1?
- orb1300411
- Histone demethylase inhibitor J1
- SCHEMBL29353127
- SCHEMBL29371558
- BDBM195611
- EBC-14080
- HB1405
- CCG-268518
- CS-3322
- GSK-J1, >=98% (HPLC)
- SB19353
- NCGC00347943-01
- NCGC00347943-09
- NCGC00347943-11
Look up GSK-J1 in the interactive SynDRA portal →